We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

190 hedge funds and large institutions have $1.38B invested in Cardiovascular Systems, Inc. in 2019 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 63 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 25

10% more capital invested

Capital invested by funds: $1.26B → $1.38B (+$124M)

2% more funds holding

Funds holding: 186190 (+4)

3% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 65

32% less call options, than puts

Call options by funds: $678K | Put options by funds: $999K

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
190
Holders Change
+4
Holders Change %
+2.15%
% of All Funds
4.13%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
32
Increased
63
Reduced
65
Closed
25
Calls
$678K
Puts
$999K
Net Calls
-$321K
Net Calls Change
+$1.29M
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$9.26M -$6.9M -177,803 -45%
Charles Schwab
27
Charles Schwab
California
$8.67M +$99.9K +2,575 +1%
GKIM
28
GW&K Investment Management
Massachusetts
$8.29M -$99.4K -2,560 -1%
FLAM
29
First Light Asset Management
Minnesota
$8.12M +$35.7K +921 +0.5%
GF
30
Gabelli Funds
New York
$8.11M -$1.08M -27,866 -13%
PPA
31
Parametric Portfolio Associates
Washington
$7.68M +$1.33M +34,146 +24%
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$7.1M -$273K -7,026 -4%
Morgan Stanley
33
Morgan Stanley
New York
$6.92M -$172K -4,439 -3%
FPC
34
Falcon Point Capital
California
$6.89M +$643K +16,577 +12%
Man Group
35
Man Group
United Kingdom
$6.48M -$1.42M -36,649 -20%
EAM
36
Eagle Asset Management
Florida
$6.46M +$4.44M +114,381 +317%
TAM
37
THB Asset Management
Connecticut
$6.19M -$526K -13,564 -9%
GI
38
GAMCO Investors
Connecticut
$5.87M -$64K -1,650 -1%
Wells Fargo
39
Wells Fargo
California
$5.61M +$644K +16,590 +15%
BA
40
Broadview Advisors
Wisconsin
$5.29M +$3.23M +83,275 +208%
USAA
41
United Services Automobile Association
Texas
$5.09M -$88.7K -2,284 -2%
Millennium Management
42
Millennium Management
New York
$5M +$4.52M +116,410 New
Goldman Sachs
43
Goldman Sachs
New York
$4.86M -$5.82M -150,048 -57%
TA
44
Teton Advisors
New York
$4.58M -$172K -4,440 -4%
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$4.42M -$56.9K -1,467 -1%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$4.39M +$41.3K +1,063 +1%
Barclays
47
Barclays
United Kingdom
$4.18M +$2.48M +63,957 +192%
MPI
48
Mairs & Power Inc
Minnesota
$4.18M +$72.9K +1,878 +2%
AAMU
49
Amundi Asset Management US
Massachusetts
$4.08M -$194K -5,000 -5%
MSL
50
Mackay Shields LLC
New York
$3.98M +$3.6M +92,800 New

CSII Hedge Fund Activity: Q2 2019 in Review

190 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2019, worth a combined $1.38B — up 9.8% from $1.26B a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new CSII positions and 25 closed out — a net gain of 7 holders — while 63 added to existing stakes and 65 trimmed.

The largest buyer was Brown Capital Management, adding an estimated $31.5M. The largest seller was Fidelity Investments, cutting an estimated $13.5M.

  • 190 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2019, up from 186 in Q1 2019.
  • Funds reported $1.38B of Cardiovascular Systems, Inc. stock for Q2 2019, up 9.8% quarter-over-quarter.
  • 32 funds opened new Cardiovascular Systems, Inc. positions in Q2 2019 and 25 closed out, a net change of +7 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2019 was Brown Capital Management, an estimated $31.5M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2019 was Fidelity Investments, an estimated $13.5M sold.

Based on aggregated 13F filings for Q2 2019.